ANGO vs JLL · rev $292.5M vs P/E 23, rev $23.43B
AngioDynamics Inc (ANGO) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported JLL revenue for 2024-12-31 was $23.43B. Net income was $546.8M. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
ANGO currently screens at market cap $378.5M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the ANGO and JLL stock pages for the full models.
Not investment advice.